Finding relief in the aftermath of Hurricane Maria: A patient’s journey from Puerto Rico to the National Institutes of Health
Jesus Garces-Soto and his wife, Lyssette Santiago, never expected to travel from Puerto Rico to the National Institutes of Health (NIH) in Bethesda, Maryland. On the same day that Hurricane Maria, a storm with 150-mile-per-hour winds, made direct landfall on Puerto Rico in 2017, Garces-Soto needed to seek treatment for an infection related to bladder cancer. Destruction from the hurricane took out the hospital’s electricity, and with no generator, it was difficult to provide adequate care. With help from members of the American Cancer Society and the National Cancer Institute, Garces-Soto and Santiago were flown to NIH where Garces-Soto is receiving care from Andrea Apolo, M.D., Investigator and Lasker Clinical Research Scholar in the Genitourinary Malignancies Branch. Read more...
CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award
Posted: Sep 6, 2017
Douglas Lowy, M.D., and John Schiller, Ph.D., of CCR’s Laboratory of Cellular Oncology have received the 2017 Lasker~DeBakey Clinical Medical Research Award for their groundbreaking research leading to the development of human papillomavirus (HPV) vaccines. The Lasker Awards are widely regarded as the country’s most prestigious biomedical research prizes.
Posted: Aug 29, 2017
In an upcoming phase II clinical trial, Center for Cancer Research investigators will explore the ability of a targeted radioactive drug to treat inoperable pheochromocytoma and paraganglioma, both rare tumors. Learn more...
Posted: Aug 29, 2017
The Biophysical Society has selected Sriram Subramaniam, Ph.D., Senior Investigator in the Laboratory of Cell Biology, as a 2018 Fellow for his seminal contributions to the cryo-EM field and related disciplines, including electron tomography and focused ion beam imaging. Along with other distinguished members who have demonstrated excellence in science and contributed to the expansion of the field of biophysics, Dr. Subramaniam will be honored during the Awards Ceremony of the Biophysical Society’s Annual Meeting on February 19, 2018 in San Francisco. Learn more...
Posted: Aug 23, 2017
A new clinical trial aims to determine whether nivolumab, an immune checkpoint inhibitor, can improve control of cancer for patients with several types of tumors of the central nervous system (CNS). The CNS is composed of the brain and spinal cord and the cause of most CNS tumors in adults is unknown. Learn more...
Posted: Aug 18, 2017
Believe it or not, camp was a favorite part of summer for Nesma Aly from 2008 to 2016. When Nesma was nine months old she was diagnosed with osteopetrosis, a rare congenital disorder in which bones become prone to break easily due to an imbalance in bone formation and breakdown. Camp Fantastic is distinctive in that it provides a normal camping experience for a unique group: children between the ages of 7 and 19 who are undergoing cancer treatment presently or in the last three years, or a bone marrow transplant in the last five years. The 2017 Camp Fantastic session runs August 13-19. Read more...
Posted: Aug 17, 2017
Leading up to the premiere of the three-part documentary, First in Human, Discovery hosted a Twitter chat on Wednesday, August 9, 2017, to discuss clinical trials and the making of the film. Stephanie Goff, M.D., Staff Clinician in the Surgery Branch, and Terry Fry, M.D., Investigator in the Pediatric Oncology Branch, represented the Center for Cancer Research in the chat. This Storify post recaps the chat and gives the audience an inside look at the making of the documentary.
Posted: Aug 17, 2017
More than three years after treatment, some clinical trial participants who received CAR T-cell therapy for diffuse large B-cell lymphoma remain in remission. These results are reported in a paper in Molecular Therapy by James Kochenderfer, M.D., of CCR's Experimental Transplantation and Immunology Branch. “This raises the possibility that CAR T cells can be curative for diffuse large B cell lymphoma,” Kochenderfer says.
Posted: Aug 16, 2017
Kevin Camphausen, M.D., Chief of CCR’s Radiation Oncology Branch, is among 23 distinguished members of the American Society for Radiation Oncology (ASTRO) to receive fellowship designation. Since 2006, the ASTRO Fellowship has been awarded to physicians and medical physicists making significant contributions to the field of radiation oncology in research, patient care, education and leadership. Dr. Camphausen will receive his award during ASTRO’s Annual Meeting, held September 24-27, 2017, in San Diego.
Posted: Aug 15, 2017
The Krebs cycle is part of the complex process where cells turn food into energy. One of the elements of the Krebs cycle is succinate dehydrogenase (SDH). Loss of SDH activity in cells has been linked to tumor formation. This new trial is studying guadecitabine for tumors associated with Krebs cycle dysfunction. Learn more...
Posted: Aug 14, 2017
A new study published August 10, 2017, in Molecular Cell reveals how changes in the architecture of the nucleus can enable B lymphocytes to spring to action during an immune system attack and help fight infection. The discovery could lead scientists to a better understanding of how some tumor cells, especially blood cancer cells, make similar transitions from a dormant to an active state. Read more. . .